The Latest Breaking News from Tempus

Tempus AI stock crashed Tuesday as investors questioned the medical AI company's long-term growth prospects.

Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review.

AI healthcare stock Tempus AI has seen its value fall off a cliff recently. However, Wall Street remains bullish, seeing significant upside in the shares.

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

The Dow Jones index fell on the stock market today. Cathie Wood bought a plunging AI stock while a Warren Buffett play is near an entry. MicroStrategy rose while Super Micro dived

The Dow Jones rallied on the stock market today. Palantir stock soared on its S&P 500 nod. Cathie Wood snapped up a plunging AI stock.

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

Big debuts from Reddit and Astera Labs are raising hope the IPO market has finally rebounded. But it’s still not the soaring, go-go days of 2021.

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….